Immunovant, Inc.
IMVTNASDAQHealthcare● Active
$30.82
$-0.29(-0.92%)
Market Cap$6.3B
P/E Ratio—
52W High$36.285
52W Low$14.32
Immunovant, Inc.（IMVT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IMVT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.46B | $0.36B | $0.21B | $0.16B | $0.10B |
| G&A Expenses | $0.08B | $0.08B | $0.06B | $0.05B | $0.05B |
| Total Operating Expenses | $0.53B | $0.44B | $0.27B | $0.21B | $0.16B |
| Operating Income | ($0.53B) | ($0.44B) | ($0.27B) | ($0.21B) | ($0.16B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.03B | $0.02B | $0.02B | $0.01B | — |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.01B | — |
| Income Before Tax | ($0.51B) | ($0.41B) | ($0.26B) | ($0.21B) | ($0.16B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.51B) | ($0.41B) | ($0.26B) | ($0.21B) | ($0.16B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 |
| Wtd Avg Shares | 0.18B | 0.15B | 0.14B | 0.12B | 0.11B |
| EBITDA | ($0.53B) | ($0.44B) | ($0.27B) | ($0.21B) | ($0.16B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Immunovant, Inc.
关于Immunovant, Inc.（IMVT）损益表
Immunovant, Inc.（IMVT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年，IMVT实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.51B)（净利率—）。
常见问题
IMVT · 4 问Immunovant, Inc.（IMVT）2026财年营收为$0.00B，同比down—%。
IMVT revenueIMVT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08